| Bioactivity | Sobuzoxane (MST-16) is an orally active topoisomerase II inhibitor. Sobuzoxane causes irreversible inhibition of cell division. Sobuzoxane can be used in the study of non-Hodgkin's lymphoma that is resistant to conventional chemotherapy or has recurred[1]. |
| CAS | 98631-95-9 |
| Formula | C22H34N4O10 |
| Molar Mass | 514.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Okamoto T, et al. Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin’s lymphoma[J]. Acta Haematologica, 2001, 104(2-3): 128-130. |
Sobuzoxane
CAS: 98631-95-9 F: C22H34N4O10 W: 514.53
Sobuzoxane (MST-16) is an orally active topoisomerase II inhibitor. Sobuzoxane causes irreversible inhibition of cell di
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.